Extended treatment of Cushing’s disease with pasireotide: results from a 2-year, Phase II study - Boscaro, M; Bertherat, J; Findling, J; Fleseriu, M; Atkinson, A B; Petersenn, S; Schopohl, J; Snyder, P; Hughes, G; Trovato, A; Hu, K; Maldonado, M; Biller, B M (Pituitary, 2014)